Publication | Open Access
Sorafenib Metabolism Is Significantly Altered in the Liver Tumor Tissue of Hepatocellular Carcinoma Patient
58
Citations
35
References
2014
Year
Sorafenib metabolism was remarkably decreased in THLMs. This result was associated with the down regulation of the protein expression of CYP3A4 and UGT1A9.
| Year | Citations | |
|---|---|---|
Page 1
Page 1